Intrinsic Value of S&P & Nasdaq Contact Us

Avalo Therapeutics, Inc. AVTX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
43/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$44.50
+220.1%

Avalo Therapeutics, Inc. (AVTX) has 12 identified peers for comparison in the Healthcare sector. Peers include ACLX, ACRV, ALXO, ALZN, ANAB, ANEB and others.

AVTX has a market capitalization of $156.99M, compared to an average peer market cap of $1.17B. AVTX is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message